» Articles » PMID: 33598202

Involvement of 5-HT-BDNF Signaling Axis in Mediating Synergistic Antidepressant-like Effects After Combined Administration of Two Oligosaccharide Esters

Overview
Journal Food Sci Nutr
Specialty Biotechnology
Date 2021 Feb 18
PMID 33598202
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Potential mechanisms of depression involving herbal medicines and their specific compounds include elevated 5-HT level and downstream BDNF pathway. To identify potentially new combined therapeutic strategies, 3,6'-disinapoylsucrose (DISS) and tenuifoliside A (TFSA) have been observed to show antidepressant-like effects and its related 5-HT-BDNF pathway. We have tried to investigate whether combined administration of DISS and TFSA exerted more effective in the treatment of depression, as assessed through tail suspension test (TST) and forced swimming test (FST). In addition, we also analyzed the expression of three important proteins, cyclic adenosine monophosphate (cAMP) response element binding (CREB), brain-derived neurotrophic factor (BDNF), and cAMP-regulated transcriptional coactivators (CRTC1), which have been shown to be involved in the regulation of the neurotrophic factors in the hippocampus. The DISS and TFSA separately, both at a dose of 5 mg/kg each, displayed small effect in the immobility time. However, combined treatment of these two in multiple doses exhibited better effect. Moreover, combined treatment of DISS and TFSA also demonstrated enhanced levels of 5-hydroxytryptamine (5-HT), and stronger increase in the phosphorylation levels of CREB, BDNF, and CRTC1 proteins in the hippocampus. Overall, our results indicated that coadministration of these two oligosaccharide esters at low dose may induce more pronounced antidepressant activity, in comparison with individual treatment even at high dosage. Thus, the antidepressant properties of both these compounds can be attributed to their ability to influence 5-HT and BDNF pathway, and thereby suggesting that this combination strategy can definitely act as alternative therapy for depression disorder with very limited side effects.

Citing Articles

Hesperidin reduces depressive symptoms in post-coronary artery bypass graft patients with mild depression.

Khorasanian A, Jazayeri S, Omidi N, Booyani Z, Morvaridi M, Tehrani-Doost M Food Sci Nutr. 2023; 11(12):7742-7750.

PMID: 38107143 PMC: 10724602. DOI: 10.1002/fsn3.3692.


Brain-derived Neurotrophic Factor and Its Applications through Nanosystem Delivery.

Xia M, Zhao T, Wang X, Li Y, Li Y, Zheng T Iran J Pharm Res. 2022; 20(4):137-151.

PMID: 35194435 PMC: 8842625. DOI: 10.22037/ijpr.2021.115705.15484.


Exploring the Role and Potential of Probiotics in the Field of Mental Health: Major Depressive Disorder.

Johnson D, Thurairajasingam S, Letchumanan V, Chan K, Lee L Nutrients. 2021; 13(5).

PMID: 34065187 PMC: 8161395. DOI: 10.3390/nu13051728.


Involvement of 5-HT-BDNF signaling axis in mediating synergistic antidepressant-like effects after combined administration of two oligosaccharide esters.

Yang W, Shi Z, Dong X, Liu P, Chen M, Hu Y Food Sci Nutr. 2021; 9(2):1180-1191.

PMID: 33598202 PMC: 7866620. DOI: 10.1002/fsn3.2098.

References
1.
Hu Y, Liu M, Liu P, Guo D, Wei R, Rahman K . Possible mechanism of the antidepressant effect of 3,6'-disinapoyl sucrose from Polygala tenuifolia Willd. J Pharm Pharmacol. 2011; 63(6):869-74. DOI: 10.1111/j.2042-7158.2011.01281.x. View

2.
Hu Y, Liao H, Dai-Hong G, Liu P, Wang Y, Rahman K . Antidepressant-like effects of 3,6'-disinapoyl sucrose on hippocampal neuronal plasticity and neurotrophic signal pathway in chronically mild stressed rats. Neurochem Int. 2009; 56(3):461-5. DOI: 10.1016/j.neuint.2009.12.004. View

3.
Hu Y, Liu M, Liu P, Dong X, Boran A . Neuroprotective effects of 3,6'-disinapoyl sucrose through increased BDNF levels and CREB phosphorylation via the CaMKII and ERK1/2 pathway. J Mol Neurosci. 2014; 53(4):600-7. DOI: 10.1007/s12031-013-0226-y. View

4.
Chen Z, Chen W, Wang Z, Cao D, Wu N, Li J . Antidepressant-like action of agmatine in the acute and sub-acute mouse models of depression: a receptor mechanism study. Metab Brain Dis. 2018; 33(5):1721-1731. DOI: 10.1007/s11011-018-0280-9. View

5.
Wang X, Gao J, Wang X, Mu X, Wei S, Xue L . Treatment with Shuyu capsule increases 5-HT1AR level and activation of cAMP-PKA-CREB pathway in hippocampal neurons treated with serum from a rat model of depression. Mol Med Rep. 2017; 17(3):3575-3582. PMC: 5802157. DOI: 10.3892/mmr.2017.8339. View